Table 1 Overall Characteristics of the population
No. of patients, n = 97 | |
|---|---|
Clinical parameters | |
Age | 63.61 (11.12) |
Sex | |
M | 81 (83.5%) |
F | 16 (16.5%) |
Histological subtype | |
SCC | 75 (77.3%) |
OA | 22 (22.7%) |
T | |
2 | 13 (14.4%) |
3 | 74 (82.2%) |
4 | 3 (3.3%) |
N | |
0 | 15 (15.6%) |
1 | 75 (78.1%) |
2 | 4 (4.2%) |
3 | 2 (2.1%) |
M | |
0 | 80 (82.5%) |
1 | 17 (17.5%) |
TNM Stage | |
I-II | 25 (25.7%) |
III-IV | 72 (74.2%) |
Tumour location | |
Upper | 20 (20.6%) |
Mean | 35 (36.1%) |
Low | 42 (43.3%) |
WHO Stage | |
0 | 46 (47.4%) |
1 | 45 (46.4%) |
> 1 | 6 (6.2%) |
Nutritional parameters | |
NRI | |
> 97.5 | 41 (52.6%) |
97.5–83.5 | 32 (41.0%) |
< 83.5 | 5 (6.4%) |
Albumin levels (g/l) | 38.91 (5.14) |
Weight (kg) | 69.39 (14.84) |
Size (m) | 1.7 [1.45–1.85] |
BMI | 24.08 (5.00) |
Weight loss (%) | 7.00 [0.00–32] |
Anthropometric parameters | |
SML3 (cm2) | 143.57 (29.15) |
VFML3 (cm2) | 109.33 [5.80, 418.29] |
SCFML3 (cm2) | 121.43 [4.20, 432.99] |
Mean Density (HU) | 30.59 (7.64) |
SMI | 49.59 (8.72) |
18FDG-PET/CT parameters | |
TVol40 | 13.50 [1.90, 140.40] |
SUVmean | 6.30 [1.90, 16.60] |
SUVmax | 11.50 [3.60, 27.90] |
TLG | 94.5 [6.9–1294] |